ReviewOncology letters2025
Functions and mechanisms of long non-coding RNA in esophageal squamous cell carcinoma (Review).
Review in Oncology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Breg-associated lncRNA signature predicts prognosis and immune landscape in esophageal carcinoma.Translational cancer research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Esophageal cancer (EC) is a highly prevalent and lethal malignancy of the digestive system, characterized by a complex pathogenesis involving multigene abnormalities and epigenetic regulation. Long non-coding RNAs (lncRNAs) are key regulatory elements in esophageal squamous cell carcinoma (ESCC). lncRNAs, defined as ncRNA molecules >200 nucleotides in length, modulate gene expression through diverse mechanisms, including epigenetic modification, competing endogenous RNA networks and RNA-protein interactions. lncRNAs participate in regulating key biological processes in ESCC, such as tumor cell proliferation, invasion, metastasis, apoptosis, drug resistance, radioresistance, stem cell properties and epithelial-mesenchymal transition. The present review summarizes the regulatory roles of lncRNAs in ESCC pathophysiology and their potential clinical application, emphasizing specific regulatory axes and mechanistic pathways implicated in esophageal carcinogenesis. Future studies should explore the molecular mechanisms of lncRNAs and their translational application to improve prognostic outcomes for patients with ESCC and identify novel therapeutic targets. These efforts may provide innovative strategies and directions for advancing precision oncology in ESCC management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.